As of 2025-07-13, the EV/EBITDA ratio of Innovation Pharmaceuticals Inc (IPIX) is 0.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IPIX's latest enterprise value is -0.12 mil USD. IPIX's TTM EBITDA according to its financial statements is -7.16 mil USD. Dividing these 2 quantities gives us the above IPIX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-07-01 | 0.02 |
| 2025-06-30 | 0.02 |
| 2025-06-26 | 0.02 |
| 2025-06-25 | 0.02 |
| 2025-06-23 | 0.02 |
| 2025-06-17 | 0.02 |
| 2025-06-16 | 0.02 |
| 2025-06-13 | 0.01 |
| 2025-06-12 | 0.02 |
| 2025-06-11 | 0.02 |
| 2025-06-10 | 0.02 |
| 2025-06-09 | 0.02 |
| 2025-06-06 | 0.02 |
| 2025-06-05 | 0.02 |
| 2025-06-04 | 0.02 |
| 2025-06-03 | 0.02 |
| 2025-06-02 | 0.02 |
| 2025-05-30 | 0.02 |
| 2025-05-29 | 0.01 |
| 2025-05-28 | 0.02 |
| 2025-05-27 | 0.02 |
| 2025-05-22 | 0.02 |
| 2025-05-20 | -0.00 |
| 2025-05-19 | 0.00 |
| 2025-05-16 | 0.02 |
| 2025-05-15 | 0.02 |
| 2025-05-14 | 0.02 |
| 2025-05-12 | 0.01 |
| 2025-05-09 | 0.00 |
| 2025-05-08 | 0.00 |
| 2025-05-07 | 0.00 |
| 2025-05-06 | 0.01 |
| 2025-05-05 | 0.01 |
| 2025-05-02 | 0.01 |
| 2025-05-01 | 0.01 |
| 2025-04-30 | 0.01 |
| 2025-04-29 | 0.02 |
| 2025-04-28 | 0.02 |
| 2025-04-25 | -0.00 |
| 2025-04-23 | 0.01 |
| 2025-04-22 | 0.01 |
| 2025-04-21 | 0.02 |
| 2025-04-17 | 0.02 |
| 2025-04-15 | 0.02 |
| 2025-04-14 | 0.02 |
| 2025-04-11 | 0.02 |
| 2025-04-10 | 0.02 |
| 2025-04-09 | 0.02 |